Allegis Investment Advisors buys $1,069,616 stake in HCP (HCP)

HCP (HCP) : Allegis Investment Advisors scooped up 5,597 additional shares in HCP during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 8, 2016. The investment management firm now holds a total of 27,739 shares of HCP which is valued at $1,069,616.HCP makes up approximately 0.52% of Allegis Investment Advisors’s portfolio.

Other Hedge Funds, Including , Autus Asset Management reduced its stake in HCP by selling 1,650 shares or 18.08% in the most recent quarter. The Hedge Fund company now holds 7,474 shares of HCP which is valued at $288,197. HCP makes up approx 0.06% of Autus Asset Management’s portfolio.Sfe Investment Counsel reduced its stake in HCP by selling 4,190 shares or 1.63% in the most recent quarter. The Hedge Fund company now holds 252,210 shares of HCP which is valued at $9,858,889. HCP makes up approx 4.42% of Sfe Investment Counsel’s portfolio. Bank Of Hawaii sold out all of its stake in HCP during the most recent quarter. The investment firm sold 17,260 shares of HCP which is valued $674,693.Anchor Capital Advisors reduced its stake in HCP by selling 1,719,877 shares or 99.27% in the most recent quarter. The Hedge Fund company now holds 12,624 shares of HCP which is valued at $493,472. HCP makes up approx 0.01% of Anchor Capital Advisors’s portfolio.Bollard Group boosted its stake in HCP in the latest quarter, The investment management firm added 533 additional shares and now holds a total of 32,047 shares of HCP which is valued at $1,246,628. HCP makes up approx 0.08% of Bollard Group’s portfolio.

HCP opened for trading at $39.13 and hit $39.505 on the upside on Monday, eventually ending the session at $39.49, with a gain of 0.92% or 0.36 points. The heightened volatility saw the trading volume jump to 38,07,247 shares. Company has a market cap of $18,465 M.

On the company’s financial health, HCP reported $0.71 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 9, 2016. Analyst had a consensus of $0.70. The company had revenue of $662.20 million for the quarter, compared to analysts expectations of $623.74 million. The company’s revenue was up 9.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.79 EPS.

Many Wall Street Analysts have commented on HCP. Company shares were Reiterated by Mizuho on Aug 10, 2016 to “Neutral”, Firm has raised the Price Target to $ 37 from a previous price target of $32 .HCP was Initiated by Raymond James to “Underperform” on Jul 26, 2016. HCP was Upgraded by Goldman to ” Neutral” on Jul 8, 2016.

HCP Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing post-acute/skilled nursing life science medical office and hospital. Its portfolio includes owned portfolio unconsolidated joint ventures and developments and redevelopments. Its owned portfolio includes around 1040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing life science and medical office segments. It has assets under development redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments which are under development or redevelopment include Pacific Corporate Park Memorial Hermann Sky Ridge Bayfront Folsom and Deer Park.

Leave a Reply

HCP - Is it time to Sell?

Top Brokerage Firms are advising their investors on HCP. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.